Arranta Bio, a Recipharm company and CDMO supporting advanced therapies, has doubled capacity at its Watertown, MA facility for process development services supporting RNA therapeutics. This major development comes less than a year after the acquisition of Arranta Bio by Recipharm, demonstrating Recipharm’s continued focus on the advanced therapeutics market. The expansion includes the fit out of approximately 2,000 ft2 of state-of-the-art laboratory space with flexible, modular small scal...